ConductScience.org, home

Trial · NCT01931839

Adverse events7,364

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherContusionInjury, poisoning and procedural complicationsArm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h7335
otherContusionInjury, poisoning and procedural complicationsArm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h3178
otherContusionInjury, poisoning and procedural complicationsArm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h8340
otherContusionInjury, poisoning and procedural complicationsArm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h3176
otherContusionInjury, poisoning and procedural complicationsArm 5 Part A: Observational Cohort00
otherContusionInjury, poisoning and procedural complicationsArm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h055
otherContusionInjury, poisoning and procedural complicationsArm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h060
otherProcedural painInjury, poisoning and procedural complicationsArm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h10335
otherProcedural painInjury, poisoning and procedural complicationsArm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h3178
otherProcedural painInjury, poisoning and procedural complicationsArm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h8340
otherProcedural painInjury, poisoning and procedural complicationsArm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h0176
otherProcedural painInjury, poisoning and procedural complicationsArm 5 Part A: Observational Cohort00
otherProcedural painInjury, poisoning and procedural complicationsArm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h055
otherProcedural painInjury, poisoning and procedural complicationsArm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h260
otherLigament sprainInjury, poisoning and procedural complicationsArm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h5335
otherLigament sprainInjury, poisoning and procedural complicationsArm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h2178
otherLigament sprainInjury, poisoning and procedural complicationsArm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h5340
otherLigament sprainInjury, poisoning and procedural complicationsArm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h6176
otherLigament sprainInjury, poisoning and procedural complicationsArm 5 Part A: Observational Cohort00
otherLigament sprainInjury, poisoning and procedural complicationsArm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h255

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01931839/events